2m 2m 2m 2m 2m 2m 2m
DISC MEDICINE (IRON)
NASDAQ
$70.53-$0.27 (-0.39%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.7BMarket Cap
- 37.00%1-Year Change
- BiotechnologyIndustry
DISC MEDICINE (IRON)
$70.53-$0.27 (-0.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 65.4M +97.83% | 33.0M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -170.6M +76.52% | -96.7M +39.57% | -69.3M +107.15% | -33.4M -31.36% | |
Depreciation and Amortization Expense | 281,000 +80.13% | 156,000 +56.00% | 100,000 +12.36% | 89,000 -61.47% | |
Total Operating Expenses | 236.0M +81.95% | 129.7M +42.35% | 91.1M +91.94% | 47.5M -31.20% | |
Operating Profit | -236.0M +81.95% | -129.7M +42.35% | -91.1M +91.94% | -47.5M -31.20% | |
Interest Income | 27.8M +30.38% | 21.3M +43.89% | 14.8M +1,987.02% | 709,000 +4,626.67% | |
Interest Expense | -3.6M +500.00% | -600,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 24.2M +16.76% | 20.7M +39.84% | 14.8M +1,987.02% | 709,000 +133.08% | |
Total Nonoperating Income and Expense | 24.2M +16.80% | 20.7M +40.03% | 14.8M +2,183.18% | 648,000 +5,084.62% | |
Income before Taxes | -211.8M +94.33% | -109.0M +42.80% | -76.3M +63.00% | -46.8M -32.14% | |
Income Taxes | 361,000 +1.69% | 355,000 +258.59% | 99,000 N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -212.2M +94.03% | -109.4M +43.08% | -76.4M +63.22% | -46.8M -34.84% | |
Net Income from Continuing Operations Applicable to Common | -211.8M +94.33% | -109.0M +42.62% | -76.4M +63.22% | -46.8M -34.84% | |
Basic EPS and Net Income | -6.01 +51.77% | -3.96 +15.79% | -3.42 -92.41% | -45.05 +2,430.90% | |
Diluted EPS and Net Income | -6.01 +51.77% | -3.96 +15.79% | -3.42 -92.41% | -45.05 +2,430.90% | |
Basic Weighted Average Shares | 35.3M +27.85% | 27.6M +23.71% | 22.3M +2,046.81% | 1.0M -97.42% | |
Diluted Weighted Average Shares | 35.3M +27.85% | 27.6M +23.71% | 22.3M +2,046.81% | 1.0M -97.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 91.1M -52.64% | 192.4M -46.60% | 360.4M +85.18% | 194.6M +42.44% | |
Short-Term Investments | 700.0M +135.34% | 297.4M N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 791.2M +61.50% | 489.9M +35.93% | 360.4M +85.18% | 194.6M +42.44% | |
Total Current Assets | 803.9M +62.86% | 493.6M +34.99% | 365.7M +84.22% | 198.5M +41.68% | |
Accumulated Depreciation | N/A N/A | 401,000 +63.67% | 245,000 +68.97% | 145,000 N/A | |
Property and Plant and Equipment and Net | 1.2M +54.33% | 751,000 +341.76% | 170,000 +1.19% | 168,000 N/A | |
Total Long-Term Assets | 726,000 -13.37% | 838,000 +258.12% | 234,000 +101.72% | 116,000 -51.05% | |
Total Assets | 806.9M +62.42% | 496.8M +34.99% | 368.0M +83.81% | 200.2M +42.56% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 36.6M +57.15% | 23.3M +8.76% | 21.4M -5.04% | 22.6M +52.20% | |
Total Long-Term Debt | 29.2M +2.96% | 28.3M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 30.4M +1.81% | 29.9M +1,980.08% | 1.4M +39.82% | 1.0M N/A | |
Total Liabilities | 67.1M +26.07% | 53.2M +132.51% | 22.9M -3.09% | 23.6M +51.35% | |
Retained Earnings | -510.2M +71.20% | -298.0M +57.97% | -188.6M +68.11% | -112.2M -39.24% | |
Total Stockholders Equity | 739.8M +66.78% | 443.6M +28.53% | 345.1M +95.43% | 176.6M +41.46% | |
Total Shares Outstanding | 37.9M +26.87% | 29.9M +22.60% | 24.4M +39.97% | 17.4M -59.72% | |
Cash Flow | |||||
Cash from Operating Activities | -180.4M +92.06% | -93.9M +27.86% | -73.5M +73.87% | -42.3M -29.23% | |
Capital Expenditures | 933,000 +84.75% | 505,000 +467.42% | 89,000 -41.06% | 151,000 +112.68% | |
Cash from Investing Activities | -394.3M +34.88% | -292.3M +328,362.92% | -89,000 -41.06% | -151,000 -143.90% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 473.4M +116.85% | 218.3M -8.80% | 239.4M +60.68% | 149.0M -22.20% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -32.55% +28.71% | -25.29% -5.99% | -26.90% -2.15% | -27.49% -49.78% | |
Return on Equity | -35.86% +29.31% | -27.73% -5.35% | -29.30% -5.70% | -31.07% -71.94% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 21.94 +3.63% | 21.17 +24.13% | 17.06 +94.01% | 8.79 -6.92% | |
Cash Ratio | 2.49 -69.86% | 8.25 -50.90% | 16.81 +95.02% | 8.62 -6.42% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow